Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LT-NS001 vs Naprosyn in Knee Osteoarthritis
NCT01063920Phase 3Completed
- Sponsor
- Logical Therapeutics
- Start
- Feb 2010
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of naproxen etemesil in osteoarthritis (OA), sponsored by Logical Therapeutics. Started Feb 2010; status: completed.
02
Drugs
naproxen etemesil
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01063920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01063920.